In postmenopausal women with type 2 diabetes, oral hormone replacement therapy (HRT) may increase the risk of CV events.
News-Medical.Net on MSN
Inflammation at the heart’s core: What clinicians and families can do now
Chronic low-grade inflammation is a key driver of cardiovascular disease, even when cholesterol is controlled. The ACC’s 2025 ...
17h
FDA Clears OsteoProbe® (K250216): First-Ever Device Indication for Measuring Bone Material Strength
Current diagnostic tools, like dual-energy X-ray absorptiometry (DXA), primarily measure bone mineral density (BMD), which explains only about 70% of bone strength variability. OsteoProbe® addresses ...
New research shows hospital blood tests can predict spinal cord injury severity and survival. Click to learn how technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback